Population Pharmacokinetics and CD20 Binding Dynamics for Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL)

被引：0
|
作者：
Bender, Brendan C. [1 ]
Li, Chi-Chung [1 ]
Marchand, Mathilde [2 ]
Turner, David C. [1 ]
Li, Feifei [1 ]
Vadhavkar, Shweta [1 ]
Wang, Bei [1 ]
Deng, Rong [1 ]
Lu, James [1 ]
Jin, Jin [1 ]
Li, Chunze [1 ]
Yin, Shen [1 ]
Wei, Michael C. [1 ]
Chanu, Pascal [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Certara Inc, Marseille, France
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma
    Mohty, Razan
    Vanegas, Yenny Moreno
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 121 - 126
  • [32] Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma
    Moleti, Maria L.
    Testi, Anna M.
    Foa, Robin
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 826 - 843
  • [33] In-field recurrences in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) bridged with radiation prior to CD19 chimeric antigen receptor T-cell therapy (CART).
    Saifi, Omran
    Breen, William
    Lester, Scott
    Rule, William G.
    Stish, Brad J.
    Rosenthal, Allison Claire
    Munoz, Javier
    Lin, Yi
    Bennani, Nabila Nora
    Paludo, Jonas
    Khurana, Arushi
    Villasboas, Jose Caetano
    Johnston, Patrick B.
    Ansell, Stephen M.
    Iqbal, Madiha
    Moustafa, Muhamad Alhaj
    Murthy, Hemant S.
    Kharfan-Dabaja, Mohamed
    Hoppe, Bradford
    Peterson, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] CC-122, a Novel Cereblon Modulating Agent, in Combination with Obinutuzumab (GA101) in Patients with Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)
    Michot, Jean-Marie
    Bouabdallah, Reda
    Doorduijn, Jeanette K.
    Vitolo, Umberto
    Kersten, Marie Jose
    Chiappella, Annalisa
    Zinzani, Pier Luigi
    Sarmiento, Rafael
    Mosulen, Silvia
    Mendez, Cristina
    Petrarca, Michael
    Pourdehnad, Michael
    Hege, Kristen
    Li, Li
    Nikolova, Zariana
    Ribrag, Vincent
    BLOOD, 2017, 130
  • [35] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [36] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
    Yuen, Sam
    Phillips, Tycel J.
    Bannerji, Rajat
    Marlton, Paula
    Gritti, Giuseppe
    Seymour, John F.
    Johnston, Anna
    Arthur, Christopher
    Dodero, Anna
    Sharma, Sunil
    Hirata, Jamie
    Musick, Lisa
    Flowers, Christopher R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
  • [37] Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)
    Abrisqueta, Pau
    Sancho, Juan-Manuel
    Cordoba, Raul
    Persky, Daniel O.
    Andreadis, Charalambos
    Huntington, Scott F.
    Carpio, Cecilia
    Giles, Daniel Morillo
    Wei, Xin
    Li, Ying Fei
    Zuraek, Marlene
    Burgess, Michael R.
    Hege, Kristen
    Martin, Alejandro
    BLOOD, 2019, 134
  • [38] Lisocabtagene maraleucel (liso-cel) treatment of patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) and secondary CNS lymphoma: Initial results from TRANSCEND NHL 001.
    Abramson, Jeremy S.
    Palomba, Maria Lia
    Arnason, Jon E.
    Lunning, Matthew Alexander
    Solomon, Scott R.
    Farazi, Thalia
    Garcia, Jacob
    Xie, Benhuai
    Newhall, Kathryn J.
    Dehner, Christine
    Siddiqi, Tanya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] CD20 mutation is associated with resistance to rituximab in a subset of patients with B-cell non-Hodgkin lymphoma
    Libra, Massimo
    Terzo, Maria N.
    Militello, Loredana
    Russo, Alessia E.
    Ligresti, Giovanni
    Russo, Mario
    Nicoletti, Ferdinando
    Stivala, Franca
    Bonavida, Benjamin
    Travali, Salvatore
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S66 - S66
  • [40] Population Pharmacokinetics of Subcutaneous Epcoritamab in Relapsed or Refractory BCell Non-Hodgkin Lymphoma
    Li, Tommy
    Gibiansky, Leonid
    Parikh, Apurvasena
    van der Linden, Marcel
    Sanghavi, Kinjal
    Putnins, Matthew
    Sacchi, Mariana
    Feng, Huaibao
    Ahmadi, Tahamtan
    Gupta, Manish
    Xu, Steven
    BLOOD, 2023, 142
12345